Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1904706 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2014 | 9 Pages |
•Variants in FTO associate with obesity.•Alterations in FTO-expression modulate energy homeostasis in mice.•FTO controls dopaminergic signaling in mice.•FTO acts as a m6A-demetylase in vivo.•FTO controls protein translation.
Genome wide association studies undoubtedly linked variants of the fat mass and obesity-associated protein (FTO) to obesity. To date, however, knowledge on the mechanisms coupling variants in the intron of the FTO gene to its expression or enzymatic activity to alter metabolism remains scarce. Until recently, the investigation of the molecular function of FTO had not led to conclusive results concerning the ‘where’, ‘when’ and ‘how’ of FTO activity. Finally, since FTO was identified as a RNA modifying enzyme, demethylating N6-methyladenosine on single stranded RNA, novel understanding of the molecular function is gathered. These and other studies suggest the requirement for a further reaching approach to further investigate FTO function, since the phenotype of aberrant FTO function may encompass more than just obesity. Taking these new insights and translating them into appropriate paradigms for functional research in humans may lead to a deeper understanding of the human physiology and disease. This article is part of a Special Issue entitled: From Genome to Function.